Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-Dose Cisplatin, Etoposide and Bleomycin (HD-PEB) Combined With Amifostine in Children With High-Risk Malignant Germ Cell Tumors - A POG Pilot Study

NCT00003811 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00003811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-Dose Cisplatin, Etoposide and Bleomycin (HD-PEB) Combined With Amifostine in Children With High-Risk Malignant Germ Cell Tumors - A POG Pilot Study
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2000
Completion date
September 30, 2007
Enrollment
27 (actual)
Sites
110

Conditions

As the registry lists them; a condition with its own page is linked.

childhood germ cell tumor, drug/agent toxicity by tissue/organ, extragonadal germ cell tumor, ovarian cancer